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BACKGROUND
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• Diabetes is a prevalent chronic health issue that leads to morbidity and
mortality in our patient population at Jefferson Hospital Ambulatory
Practice (JHAP).

< 6 months

• 30.3 million people in the US are living with diabetes mellitus. Diabetes
was the 7th leading cause of death in the US in 2015.
• The percentage of our patient population at JHAP with uncontrolled
diabetes is high with a rate that approaches 40%.

A1c > 9%

• The percentage of our patients with diabetes that had a follow up
appointment scheduled was strikingly low at 20%.
• Follow up and compliance has been a significant deterrent to optimal
diabetes management at our practice and are the main issues we
attempted to address.
• We targeted patients with uncontrolled diabetes, defined as A1C > 9% or
those without an A1c result in the last year, in accordance with our
institutional goals.

DISCUSSION
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• We successfully doubled the percentage of follow-up appointments
scheduled for patients with uncontrolled diabetes (Figure 3).
> 6 months

• Despite the increase in appointments there was no increase in
percentage of patients with controlled HbA1C (Figure 3).
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• We attribute our percent increase in follow-up success to the medical
assistants who called all diabetic patients to schedule appointments

• While we were able to improve HbA1C control for some patients, others
had worsening glycemic control, resulting in no overall improvement in
our sample.
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• Using a small random sample size, the average change in A1C after 2
visits was 0.4%, meaning we did not significantly improve glycemic
control.

RESULTS

• Patients who completed a follow-up with the pharmacist showed a 2.9%
decrease in A1C (Table 1).
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FUTURE DIRECTIONS

AIM

• Use an Epic smartphrase to provide a uniform way for providers to
document glycemic control and management.

• Increase percentage of scheduled follow up appointments in our diabetic
population by 50% within 8 months.
• Decrease percentage of uncontrolled diabetics by 10% within 8 months.

INTERVENTION
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Table 1 Pharmacist Intervention

Patient fear/ignorance
Patient non-adherence

A1c cutoff for pharmacist
referral
Resident workflow***

Appropriate follow
up appointments ***

Viewing data Epic
transition
EMR review charts

ADA guidelines*

Documentation of
decreased HgA1c

Policies

Technology

Total Number of Patients seen by
PharmD

Pre-QI Interval
(3/1/18 –8/31/18)

QI Interval
(9/1/18 – 3/6/19)

30

34

A1c decreased during interval

14 (46.7%)

16 (47.1%)

A1c increased during interval

3 (10%)

5 (14.7%)

Due for A1c

7 (23.3%)

7 (20.6%)

6 (20%)

5 (14.7%)

---

1 (2.9%)

• We believe if the clinic can can maintain this increase in followup appointments for all our diabetic patients for one year, the A1C
will trend downwards.
• Consider having a dedicated diabetes focused case manager or MA in
the clinic to organize the monthly phone calls to all diabetic patients
without follow-up.
• Continue to make follow-up with pharmacist a priority for all
patients with uncontrolled diabetes.

• Our interventions were completed between 7/2018-2/2019.
• Our primary intervention was for the MAs to call all diabetic patients and
schedule an appointment based on the algorithm below (Figure 2).
• Our secondary intervention was for uncontrolled diabetics to complete a
comprehensive diabetes care visit with our pharmacist including
medication review, medication titration, and follow up planning.

Not yet due for A1c
Deceased
Referred to PharmD but no-showed

13

8
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